Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease.
about
A Potential Alternative against Neurodegenerative Diseases: PhytodrugsWater extract of Ashwagandha leaves has anticancer activity: identification of an active component and its mechanism of actionDifferential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS.Glioprotective effects of Ashwagandha leaf extract against lead induced toxicityCNB-001 a novel curcumin derivative, guards dopamine neurons in MPTP model of Parkinson's disease.Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice.Comparative root protein profiles of Korean ginseng (Panax ginseng) and Indian ginseng (Withania somnifera).Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicityInfluences of Chronic Mild Stress Exposure on Motor, Non-Motor Impairments and Neurochemical Variables in Specific Brain Areas of MPTP/Probenecid Induced Neurotoxicity in Mice.Aqueous extract from the Withania somnifera leaves as a potential anti-neuroinflammatory agent: a mechanistic study.Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis.Pharmacologic overview of Withania somnifera, the Indian Ginseng.Antiproliferative and Antioxidant Effects of Withania coagulans Extract on Benign Prostatic Hyperplasia in Rats.Natural Withanolides in the Treatment of Chronic Diseases.Supplementation with Herbal Extracts to Promote Behavioral and Neuroprotective Effects in Experimental Models of Parkinson's Disease: A Systematic Review.Graptopetalum paraguayense E. Walther leaf extracts protect against brain injury in ischemic rats.Aqueous Leaf Extract of Withania somnifera as a Potential Neuroprotective Agent in Sleep-deprived Rats: a Mechanistic Study.Neuroprotective effects of Alpinia katsumadai against experimental ischemic damage via control of oxidative stress.Agaricus blazei extract abrogates rotenone-induced dopamine depletion and motor deficits by its anti-oxidative and anti-inflammatory properties in Parkinsonic mice.Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer's disease in Wistar rats.Efficacy of Natural Compounds in Neurodegenerative Disorders.Neuroprotective effects of Alpinia katsumadai against neuronal damage in the gerbil hippocampus induced by transient cerebral ischemia.Vanillin Attenuated Behavioural Impairments, Neurochemical Deficts, Oxidative Stress and Apoptosis Against Rotenone Induced Rat Model of Parkinson's Disease.Demethoxycurcumin, a Natural Derivative of Curcumin Abrogates Rotenone-induced Dopamine Depletion and Motor Deficits by Its Antioxidative and Anti-inflammatory Properties in Parkinsonian Rats.Plant-Derived Natural Products for Parkinson's Disease Therapy.Escin, a novel triterpene, mitigates chronic MPTP/p-induced dopaminergic toxicity by attenuating mitochondrial dysfunction, oxidative stress, and apoptosis.Extract from Terminalia chebula seeds protect against experimental ischemic neuronal damage via maintaining SODs and BDNF levels.EGCG Nanoparticles Attenuate Aluminum Chloride Induced Neurobehavioral Deficits, Beta Amyloid and Tau Pathology in a Rat Model of Alzheimer's Disease
P2860
Q26765784-4265671B-0CD0-4F21-9C89-D75464A20545Q28534335-8A9C0EEC-8D4F-46CE-A9E9-0D494FC21775Q30835468-6B17280D-085F-4B81-9639-39D9E3BA5912Q33758667-30A7481B-F696-4FC4-B338-B97BB0F39769Q33851011-5A5D0228-8375-44E1-9E02-45D9D09C4C68Q33979340-EF7F5CA2-8892-4E61-9A0E-A3D41D8DB445Q34148775-3182830B-C79C-45BC-A5CC-58C787696266Q34273861-C1D11533-E01D-48AE-A038-4EB60A49E9E4Q35893872-313A6D7E-1DF6-4309-81B1-86379F80D8A9Q37196355-88D21C65-2E9C-4DCA-AF40-F7EEC22275CCQ38398089-46EA4431-F37B-408A-A9D2-BE67510D4F29Q38573788-CB596B10-8699-4A16-B01D-F154CCBE311DQ38797324-79C1267A-F2AD-46DC-B837-8B56F4936F63Q38965226-4F8226C2-D7A7-4EB5-B8E5-CFA397BB268DQ39329775-6E3658AE-3148-4522-AB7C-EC7961D7C1F8Q39700199-5B580290-AB06-43CD-A1C2-C715999A7D60Q39870272-09A6A8A4-9432-439A-BC7E-DA93EA832212Q44171424-18AB6B35-2372-4975-931C-F967976D4E13Q48257347-F605DC43-AD55-4551-BBBF-1CAA1CAB9488Q48355470-C505CEF1-B657-4D17-BFEB-69BC0BE1BB27Q48502034-A13B47FE-2159-4D91-936E-C148EB7ED5B6Q48961507-4DEA8041-A7ED-4CC4-A483-08A0FB628F00Q50523809-F3231C39-C23D-4D4F-91F8-043D062C0615Q51759677-C11645B6-0DDB-4EB3-9B71-C3F516D4E0D8Q51800931-267B5001-B5CC-42C0-B926-5322519CD637Q53054056-48599D16-09D6-4F79-95C1-02434794E73EQ53420689-8D9C4D03-739E-4AC5-A80B-5A140ADE9CD3Q58785927-2D7DC7FF-53C4-47AD-9A37-3D11D2D420AD
P2860
Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Ashwagandha leaf extract: a po ...... model of Parkinson's disease.
@en
Ashwagandha leaf extract: a po ...... model of Parkinson's disease.
@nl
type
label
Ashwagandha leaf extract: a po ...... model of Parkinson's disease.
@en
Ashwagandha leaf extract: a po ...... model of Parkinson's disease.
@nl
prefLabel
Ashwagandha leaf extract: a po ...... model of Parkinson's disease.
@en
Ashwagandha leaf extract: a po ...... model of Parkinson's disease.
@nl
P1433
P1476
Ashwagandha leaf extract: a po ...... e model of Parkinson's disease
@en
P2093
Srinivasagam Rajasankar
P356
10.1016/J.NEULET.2009.02.044
P407
P577
2009-02-26T00:00:00Z